Lundbeckfonden Emerge
Overview
Lundbeckfonden Emerge is a strategic initiative of the Lundbeckfonden, established in the spring of 2012. The accelerator focuses on supporting early-stage life science companies with strong potential to make a significant impact in the healthcare sector. Entrepreneurs who become part of Lundbeckfonden Emerge benefit from financial investment, strategic guidance, and access to a vast network of industry experts, mentors, and potential partners. The initiative aims to nurture innovative startups through tailored support, fostering their growth and helping them achieve key milestones towards commercialization. The main objective is to turn scientific discoveries and early-stage opportunities into commercial ventures with maturity that allows for full venture financing. Lundbeckfonden Emerge not only offers limited financing for selected cases but also provides seasoned advice or direct participation in new ventures, as part of its unique model to optimize the outcome of the venture to the benefit of all stakeholders. The firm seeks to develop select projects together with founders and takes on an active role from mentoring to active project management, as is considered optimal for the outcome of the specific project. In this way, Lundbeckfonden Emerge is not a replication of traditional seed funds but rather a unique way of using research funds to get to commercially viable projects. Lundbeckfonden Emerge has a track record of co-investing in significant funding rounds, such as the $50 million investment in SNIPR Biome Limited, a company pioneering CRISPR technology to revolutionize the treatment of microbial diseases. This investment underscores the firm's commitment to advancing innovative solutions in the life sciences sector. The firm's investment philosophy emphasizes a hands-on approach, actively engaging with portfolio companies to drive growth and success. By leveraging its extensive network and expertise, Lundbeckfonden Emerge aims to accelerate the development of groundbreaking healthcare solutions that address unmet medical needs.
Reach Lundbeckfonden Emerge directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Lundbeckfonden Emerge
What sectors does Lundbeckfonden Emerge invest in?
Lundbeckfonden Emerge invests in Healthcare, Life Sciences, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in Denmark. Lundbeckfonden Emerge is listed as a venture capital in the ConnectSafely investor database.
What stage does Lundbeckfonden Emerge invest at?
Lundbeckfonden Emerge backs companies at Seed and Early Stage, writing cheques of 500K - 5M.
Which regions does Lundbeckfonden Emerge invest in?
Lundbeckfonden Emerge invests across United States, United Kingdom, Germany, France, Italy and Denmark.
Last updated · Source: ConnectSafely investor database





